At Transmural Systems we spend a lot of time thinking about the effect our product designs will have on physicians, strategic partners, hospitals and most of all, on patients thus providing an innovative portfolio of devices designed to enable simple, safe and effective therapies.

Transmural Systems, established in 2013,  is a clinical stage medical device company.  We have a  platform of percutaneous structural heart therapies.  Our team brings decades of combined implant medical device design, development, quality systems, manufacturing and commercialization experience.  The Transmural Systems team successfully advanced two of its products (Transmural Cerclage™ and Transcaval Access Closure Device) from early-stage concept to FDA investigational device exemption (IDE) approval, and is successfully executing  early feasibility studies.